New Search

Your search found 56 records, sorted by year and then date of acquisition.

1. Testing and Linkage to HIV Care in China: A Cluster-Randomised Trial. doc type
  Wu, Zunyou ; Tang, Zhenzhu ; Mao, Yurong ; VanVeldhuisen, Paul C. ; Ling, Walter ; Liu, David S. ; Shen, Zhiyong ; Detels, Roger ; Lan, Guanghua ; Erinoff, Lynda ; Lindblad, Robert ; Gu, Diane ; Tang, Houlin ; Hu, Lian ; Zhu, Qiuying ; Lu, Li ; Oden, Neal L. ; Hasson, Albert L. ; Zhao, Yan ; McGoogan, Jennifer M. ; Ge, Xianmin ; Zhang, Nanci ; Rou, Keming ; Zhu, Jinhui ; Wei, Hui ; Shi, Cynthia X. ; Jin, Xia ; Li, Jian ; Montaner, Julio S. G.
 Lancet HIV 2017 (in press). [doi: 10.1016/S2352-3018(17)30131-5].
 
2. Volatility and Change in Chronic Pain Severity Predict Outcomes of Treatment for Prescription Opioid Addiction. doc type
  Worley, Matthew J. ; Heinzerling, Keith G. ; Shoptaw, Steven ; Ling, Walter
 Addiction 2017;112(7):1202-1209. [doi: 10.1111/add.13782].
 
3. Distinctive Trajectories of Opioid Use Over an Extended Follow-Up of Patients in a Multisite Trial on Buprenorphine + Naloxone and Methadone. doc type
  Hser, Yih-Ing ; Huang, David ; Saxon, Andrew J. ; Woody, George ; Moskowitz, Andrew L. ; Matthews, Abigail G. ; Ling, Walter
 Journal of Addiction Medicine 2017;11(1):63-69. [doi: 10.1097/ADM.0000000000000274].
 
4. A Polymorphism in the OPRM1 3'-Untranslated Region is Associated with Methadone Efficacy in Treatment Opioid Dependence. doc type
  Crist, Richard C. ; Doyle, Glenn A. ; Nelson, Elliot C. ; Degenhardt, Louisa ; Martin, Nicholas G. ; Montgomery, Grant W. ; Saxon, Andrew J. ; Ling, Walter ; Berrettini, Wade H.
 Pharmacogenomics Journal 2016 (in press). [doi: 10.1038/tpj.2016.89].
 
5. NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study Design and Rationale. doc type
  Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Bailey, Genie L. ; Brigham, Gregory S. ; Cohen, Allan J. ; Fishman, Marc J. ; Ling, Walter ; Lindblad, Robert ; Shmueli-Blumberg, Dikla ; Stablein, Don ; May, Jeanine ; Salazar, Dagmar ; Liu, David S. ; Rotrosen, John
 Contemporary Clinical Trials 2016;50:253-264. [doi: 10.1016/j.cct.2016.08.004].
 
6. Participant Treatment Assignment Perceptions in the NIDA CTN Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Matthews, Abigail G. ; Hillhouse, Maureen ; Thomas, Christie ; Ling, Walter ; Shmueli-Blumberg, Dikla
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Palm Springs, CA, June 11-16, 2016.
 
7. Utilizing a Two-Stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-Daily Bupropion as a Treatment for Methamphetamine Use Disorder. doc type
  Mooney, Larissa J. ; Hillhouse, Maureen P. ; Thomas, Christie ; Ang, Alfonso ; Sharma, Gaurav ; Terry, Garth ; Chang, Linda ; Walker, N. Robrina ; Trivedi, Madhukar H. ; Croteau, David ; Sparenborg, Steven ; Ling, Walter
 Journal of Addiction Medicine 2016;10(4):236-243. [doi: 10.1097/ADM.0000000000000218].
 
8. Buprenorphine-Naloxone plus Naltrexone for the Treatment of Cocaine Dependence: The Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Ling, Walter ; Hillhouse, Maureen P. ; Saxon, Andrew J. ; Mooney, Larissa J. ; Thomas, Christie ; Ang, Alfonso ; Matthews, Abigail G. ; Hasson, Albert L. ; Annon, Jeffrey J. ; Sparenborg, Steven ; Liu, David S. ; McCormack, Jennifer ; Church, Sarah ; Swafford, William ; Drexler, Karen ; Schuman, Carolyn ; Ross, Stephen ; Wiest, Katharina L. ; Korthuis, P. Todd ; Lawson, William ; Brigham, Gregory S. ; Knox, Patricia C. ; Dawes, Michael ; Rotrosen, John
 Addiction 2016;111(8):1416-1427. [doi: 10.1111/add.13375].
 
9. Long-Term Outcomes After Randomization to Buprenorphine/Naloxone Versus Methadone in a Multi-Site Trial. doc type
  Hser, Yih-Ing ; Evans, Elizabeth ; Huang, David ; Weiss, Roger D. ; Saxon, Andrew J. ; Carroll, Kathleen M. ; Woody, George E. ; Liu, David S. ; Wakim, Paul G. ; Matthews, Abigail G. ; Hatch-Maillette, Mary A. ; Jelstrom, Eve ; Wiest, Katharina L. ; McLaughlin, Paul ; Ling, Walter
 Addiction 2016;111(4):695-705. [doi: 10.1111/add.13238].
 
10. Pain Volatility and Prescription Opioid Addiction Treatment Outcomes in Patients With Chronic Pain. doc type
  Worley, Matthew J. ; Heinzerling, Keith G. ; Shoptaw, Steven ; Ling, Walter
 Experimental and Clinical Psychopharmacology 2015;23(6):428-435. [doi: 10.1037/pha0000039].
 
11. Using Behavioral Economics to Predict Outcomes of Medication and Counseling for Prescription Opioid Dependence. doc type
  Worley, Matthew J. ; Shoptaw, Steven ; Bickel, Warren K. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Phoenix, AZ, June 13-18, 2015.
 
12. Treatment Satisfaction in the CTN Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Thomas, Christie ; Hillhouse, Maureen P. ; Ang, Alfonso ; Annon, Jeffrey J. ; Mooney, Larissa J. ; Hasson, Albert L. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Phoenix, AZ, June 13-18, 2015.
 
13. Examining the Factor Structure of the Clinical Opiate Withdrawal Scale: A Secondary Data Analysis from the National Drug Abuse Treatment Clinical Trials Network (CTN) 0003. doc type
  Barbosa-Leiker, Celestina ; McPherson, Sterling ; Mamey, Mary Rose ; Burns, G. Leonard ; Layton, Matthew E. ; Roll, John M. ; Ling, Walter
 Drug and Alcohol Dependence 2015;152:218-222. [doi: 10.1016/j.drugalcdep.2015.03.036].
 
14. Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study. doc type
  Schulte, Marya T. ; Hser, Yih-Ing ; Saxon, Andrew J. ; Evans, Elizabeth ; Li, Libo ; Huang, David ; Hillhouse, Maureen P. ; Thomas, Christie ; Ling, Walter
 Journal of Community Health 2015;40(5):940-947. [doi: 10.1007/s10900-015-0016-2].
 
15. Developing PCORI Applications for Patient-Centered SUD Treatment Research: A CTN Technical Assistance Workshop. doc type doc type
  Tai, Betty ; Chandler, Redonna K. ; Selby, Joe ; Hickam, David ; Luce, Bryan ; Ling, Walter ; Brooks, Adam ; Campbell, Cynthia ; Ford, Jay
 Workshop held at the National Institute of Drug Abuse (NIDA), January 8, 2015.
 
16. Using Behavioral Economics to Predict Opioid Use During Prescription Opioid Dependence Treatment. doc type
  Worley, Matthew J. ; Shoptaw, Steven J. ; Bickel, Warren K. ; Ling, Walter
 Drug and Alcohol Dependence 2015;148:62-68. [doi: 10.1016/j.drugalcdep.2014.12.018].
 
17. Patient Perspectives on Buprenorphine/Naloxone: A Qualitative Study of Retention During the Starting Treatment with Agonist Replacement Therapies (START) Study. doc type
  Teruya, Cheryl ; Schwartz, Robert P. ; Mitchell, Shannon G. ; Hasson, Albert L. ; Thomas, Christie ; Buoncristiani, Samantha H. ; Hser, Yih-Ing ; Wiest, Katharina ; Cohen, Allan J. ; Glick, Naomi ; Jacobs, Petra ; McLaughlin, Paul ; Ling, Walter
 Journal of Psychoactive Drugs 2014;46(5):412-426. [doi: 10.1080/02791072.2014.921743].
 
18. HIV Risk Reduction with Buprenorphine-Naloxone or Methadone: Findings from A Randomized Trial. doc type
  Woody, George E. ; Bruce, R. Douglas ; Korthuis, P. Todd ; Chhatre, Sumedha ; Hillhouse, Maureen P. ; Jacobs, Petra ; Sorensen, James L. ; Saxon, Andrew J. ; Metzger, David S. ; Ling, Walter
 Journal of Acquired Immune Deficiency Syndromes 2014;66(3):288-293. [doi: 10.1097/QAI.0000000000000165].
 
19. Genetic Variation in OPRD1 and the Response to Treatment for Opioid Dependence with Buprenorphine in European American Females. doc type
  Clarke, Toni-Kim ; Crist, Richard C. ; Ang, Alfonso ; Ambrose-Lanci, Lisa ; Lohoff, Falk W. ; Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Bruce, R. Douglas ; Woody, George E. ; Berrettini, Wade H.
 Pharmacogenomics Journal 2014;14:303-308. [doi: 10.1038/tpj.2013.30].
 
20. The Relationship Between Primary Prescription Opioid and Buprenorphine-Naloxone Induction Outcomes in a Prescription Opioid Dependent Sample. doc type
  Nielsen, Suzanne ; Hillhouse, Maureen ; Weiss, Roger D. ; Mooney, Larissa ; Potter, Jennifer Sharpe ; Lee, Joshua ; Gourevitch, Marc N. ; Ling, Walter
 American Journal on Addictions 2014;23(4):343-348. [doi: 10.1111/j.1521-0391.2013.12105.x].
 
21. Treatment Retention Among Patients Randomized to Buprenorphine/Naloxone Compared to Methadone in a Multi-Site Trial. doc type
  Hser, Yih-Ing ; Saxon, Andrew J. ; Huang, David ; Hasson, Albert ; Thomas, Christie ; Hillhouse, Maureen ; Jacobs, Petra ; Teruya, Cheryl ; McLaughlin, Paul ; Wiest, Katharina ; Cohen, Allan J. ; Ling, Walter
 Addiction 2014;109(1):79-87. [doi: 10.1111/add.12333].
 
22. Induction Onto Extended-Release Naltrexone in 302 Cocaine-Dependent Opioid Users. doc type
  Lindblad, Robert ; McCormack, Jennifer ; Saxon, Andrew J. ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Mooney, Larissa ; VanVeldhuisen, Paul C. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 15-20, 2013.
 
23. Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings from Starting Treatment with Agonist Replacement Therapies (START). doc type
  Potter, Jennifer Sharpe ; Marino, Elise N. ; Hillhouse, Maureen P. ; Nielsen, Suzanne ; Wiest, Katharina ; Canamar, Catherine P. ; Martin, Judith A. ; Ang, Alfonso ; Baker, Rachel ; Saxon, Andrew J. ; Ling, Walter
 Journal of Studies on Alcohol and Drugs 2013;74(4):605-613..
 
24. An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans. doc type
  Crist, Richard C. ; Clarke, Toni-Kim ; Ang, Alfonso ; Ambrose-Lanci, Lisa ; Lohoff, Falk W. ; Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Bruce, R. Douglas ; Woody, George E. ; Berrettini, Wade
 Neuropsychopharmacology 2013;38:2003-2010. [doi: 10.1038/npp.2013.99].
 
25. A Comparison of Buprenorphine Taper Outcomes Between Prescription Opioid and Heroin Users. doc type
  Nielsen, Suzanne ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Ling, Walter
 Journal of Addiction Medicine 2013;7(1):33-38. [doi: 10.1097/ADM.0b013e318277e92e].
 
26. Cocaine Use Reduction with Buprenorphine (CURB): Rationale, Design, and Methodology. doc type
  Mooney, Larissa J. ; Nielsen, Suzanne ; Saxon, Andrew J. ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Stablein, Don ; McCormack, Jennifer ; Lindblad, Robert ; Ling, Walter
 Contemporary Clinical Trials 2013;34(2):196-204. [doi: 10.1016/j.cct.2012.11.002].
 
27. Buprenorphine/Naloxone and Methadone Effects on Laboratory Indices of Liver Health: A Randomized Trial. doc type doc type
  Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Ang, Alfonso ; Doraimani, Geetha ; Tasissa, Gudaye ; Lokhnygina, Yuliya ; Leimberger, Jeffrey D. ; Bruce, R. Douglas ; McCarthy, John ; Wiest, Katharina ; McLaughlin, Paul ; Bilangi, Richard ; Cohen, Allan J. ; Woody, George E. ; Jacobs, Petra
 Drug and Alcohol Dependence 2013;128(1-2):71-76. [doi: 10.1016/j.drugalcdep.2012.08.002].
 
28. Predictors of Outcome After Short-Term Stabilization with Buprenorphine. doc type
  Hillhouse, Maureen P. ; Canamar, Catherine P. ; Ling, Walter
 Journal of Substance Abuse Treatment 2013;44(1):336-342. [doi: 10.1016/j.jsat.2012.08.016].
 
29. Alcohol and Drug Dependence Symptom Items as Brief Screeners for Substance Use Disorders: Results from the Clinical Trials Network. doc type
  Wu, Li-Tzy ; Blazer, Dan G. ; Woody, George E. ; Burchett, Bruce ; Yang, Chongming ; Pan, Jeng-Jong ; Ling, Walter
 Journal of Psychiatric Research 2012;46(3):360-369. [doi: 10.1016/j.jpsychires.2011.12.002].
 
30. Protocol: NIDA-CTN-0027: Starting Treatment with Agonist Replacement Therapies (START). doc type
  Ling, Walter ; Saxon, Andrew J.
 Presented at the American Public Health Association (APHA) annual meeting, Washington, DC, Oct. 28 - Nov. 2, 2011.
 
31. Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence: A 2-Phase Randomized Controlled Trial. doc type doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Fiellin, David A. ; Byrne, Mimmie ; Connery, Hilary Smith ; Dickinson, William ; Gardin, John G. II ; Griffin, Margaret L. ; Gourevitch, Marc N. ; Haller, Deborah L. ; Hasson, Albert L. ; Huang, Zhen ; Jacobs, Petra ; Kosinski, Andrzej S. ; Lindblad, Robert ; McCance-Katz, Elinore F. ; Provost, Scott E. ; Selzer, Jeffrey A. ; Somoza, Eugene C. ; Sonne, Susan C. ; Ling, Walter
 Archives of General Psychiatry 2011;68(12):1238-1246. [doi: 10.1001/archgenpsychiatry.2011.121].
 
32. Selective Review and Commentary on Emerging Pharmacotherapies for Opioid Addiction. doc type
  Ling, Walter ; Mooney, Larissa ; Zhao, Min ; Nielsen, Suzanne ; Torrington, Matthew ; Miotto, Karen
 Substance Abuse and Rehabilitation 2011;2:181-188. [doi: 10.2147/SAR.S20895].
 
33. Depressive Symptoms, Substance Use and HIV-Related High Risk Behaviors among Opioid-Dependent Individuals: Results from the Clinical Trials Network. doc type
  Pilowsky, Daniel J. ; Wu, Li-Tzy ; Burchett, Bruce ; Blazer, Dan G. ; Ling, Walter
 Substance Use & Misuse 2011;46(14):1716-1725. [doi: 10.3109/10826084.2011.611960].
 
34. Comparative Profiles of Men and Women with Opioid Dependence: Results from a National Multisite Effectiveness Trial. doc type
  Back, Sudie E. ; Payne, Rebecca ; Wahlquist, Amy Herrin ; Carter, Rickey E. ; Stroud, Zachary ; Haynes, Louise F. ; Hillhouse, Maureen P. ; Brady, Kathleen T. ; Ling, Walter
 American Journal of Drug and Alcohol Abuse 2011;37(5):313-323. [doi: 10.3109/00952990.2011.596982].
 
35. Participant Characteristics and Buprenorphine Dose. doc type
  Hillhouse, Maureen P. ; Canamar, Catherine P. ; Doraimani, Geetha ; Thomas, Christie ; Hasson, Albert L. ; Ling, Walter
 American Journal of Drug and Alcohol Abuse 2011;37(5):453-459. [doi: 10.3109/00952990.2011.596974].
 
36. Co-Occurring Amphetamine Use and Associated Medical and Psychiatric Comorbidity Among Opioid-Dependent Adults: Results from the Clinical Trials Network. doc type
  Pilowsky, Daniel J. ; Wu, Li-Tzy ; Burchett, Bruce ; Blazer, Dan G. ; Woody, George E. ; Ling, Walter
 Substance Abuse and Rehabilitation 2011;2:133-144. [doi: 10.2147/SAR.S20895].
 
37. Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction Treatment Study. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; Connery, Hilary Smith ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Hollywood, FL, June 18-23, 2011.
 
38. Cocaine Use Reduction with Buprenorphine (CURB: CTN-0048): Protocol Overview. doc type
  Mooney, Larissa ; Saxon, Andrew J. ; Ling, Walter
 Webinar sponsored by the NIDA Clinical Coordinating Center, May 11, 2011.
 
39. Use of Item Response Theory and Latent Class Analysis to Link Poly-Substance Use Disorders with Addiction Severity, HIV Risk, and Quality of Life Among Opioid-Dependent Patients in the Clinical Trials Network. doc type
  Wu, Li-Tzy ; Ling, Walter ; Burchett, Bruce ; Blazer, Dan G. ; Yang, Chongming ; Pan, Jeng-Jong ; Reeve, Bruce B. ; Woody, George E.
 Drug and Alcohol Dependence 2011;118(2-3):186-193. [doi: 10.1016/j.drugalcdep.2011.03.018].
 
40. A Community-Based, Two-Phase Randomized Controlled Trial of Buprenorphine With and Without Individual Drug Counseling for the Treatment of Opioid Analgesic Addiction. doc type
  Provost, Scott E. ; Potter, Jennifer Sharpe ; Weiss, Roger D. ; Jacobs, Petra ; Ling, Walter
 Poster presented at the American Public Health Association (APHA) Annual Meeting, Denver, CO, November 6-10, 2010..
 
41. Gender and Racial/Ethnic Differences in Addiction Severity, HIV Risk, and Quality of Life among Adults in Opioid Detoxification: Results from the National Drug Abuse Treatment Clinical Trials Network. doc type
  Wu, Li-Tzy ; Ling, Walter ; Burchett, Bruce ; Blazer, Dan G. ; Shostak, Jack ; Woody, George E.
 Substance Abuse and Rehabilitation 2010;1:13-22. [doi: 10.2147/SAR.S15151].
 
42. Craving Intensity and Withdrawal Severity Across Phases of Opioid Detoxification with Buprenorphine. doc type
  Chen, Hanhui ; Hillhouse, Maureen P. ; Doraimani, Geetha ; Hasson, Albert L. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
43. START Study Retention: Perspectives of Suboxone Dropouts. doc type
  Teruya, Cheryl ; Thomas, Christie ; Rosensteel, Anya ; Hasson, Albert L. ; Hillhouse, Maureen P. ; Hser, Yih-Ing ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
44. Implementing Research in Community Treatment Programs: Findings from a CTN Trial. doc type
  Cohen, Allan J. ; George, Dan ; Langlois, Camille ; Moreno, Ann ; Yomjinda, Dara ; Boubion, Cynthia ; Martin, Judith ; Donovick, Roger ; Thomas, Christie ; Hasson, Albert L. ; Vimieiro, Cintia ; Hillhouse, Maureen P. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
45. Association of Race and Ethnicity with Withdrawal Symptoms, Attrition, Opioid Use, and Side-Effects During Buprenorphine Therapy. doc type
  Brown, E. Sherwood ; Tirado, Carlos F. ; Minhajuddin, Abu T. ; Hillhouse, Maureen P. ; Adinoff, Bryon H. ; Ling, Walter ; Doraimani, Geetha ; Thomas, Christie
 Journal of Ethnicity in Substance Abuse 2010;9(2):106-114. [doi: 10.1080/15332641003772587].
 
46. From Research to the Real World: Buprenorphine in the Decade of the Clinical Trials Network. doc type
  Ling, Walter ; Jacobs, Petra ; Hillhouse, Maureen P. ; Hasson, Albert L. ; Thomas, Christie ; Freese, Thomas E. ; Sparenborg, Steven ; McCarty, Dennis ; Weiss, Roger D. ; Saxon, Andrew J. ; Cohen, Allan J. ; Straus, Michele M. ; Brigham, Gregory S. ; Liu, David S. ; McLaughlin, Paul ; Tai, Betty
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S53-S60. [doi: 10.1016/j.jsat.2010.01.009].
 
47. Pain and Continued Opioid Use in Individuals Receiving Buprenorphine-Naloxone for Opioid Detoxification: Secondary Analyes from the Clinical Trials Network. doc type
  Potter, Jennifer Sharpe ; Chakrabarti, Amit ; Domier, Catherine P. ; Hillhouse, Maureen P. ; Weiss, Roger D. ; Ling, Walter
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S80-S86. [doi: 10.1016/j.jsat.2009.12.007].
 
48. Multisite Effectiveness Trials of Treatments for Substance Abuse and Co-Occurring Problems: Have We Chosen the Best Designs? doc type
  Nunes, Edward V. ; Ball, Samuel A. ; Booth, Robert E. ; Brigham, Gregory S. ; Calsyn, Donald A. ; Carroll, Kathleen M. ; Feaster, Daniel J. ; Hien, Denise A. ; Hubbard, Robert L. ; Ling, Walter ; Petry, Nancy M. ; Rotrosen, John ; Selzer, Jeffrey A. ; Stitzer, Maxine L. ; Tross, Susan ; Wakim, Paul G. ; Winhusen, Theresa M. ; Woody, George E.
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S97-S112. [doi: 10.1016/j.jsat.2010.01.012].
 
49. Provision of Ancillary Medications During Buprenorphine Detoxification Does Not Improve Treatment Outcomes. doc type
  Hillhouse, Maureen P. ; Domier, Catherine P. ; Chim, David ; Ling, Walter
 Journal of Addictive Diseases 2010;29(1):23-29. [doi: 10.1080/10550880903438925].
 
50. Conducting Clinical Research with Prescription Opioid Dependence: Defining the Population. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Copersino, Marc L. ; Prather, Kristi ; Jacobs, Petra ; Provost, Scott E. ; Chim, David ; Selzer, Jeffrey A. ; Ling, Walter
 American Journal on Addictions 2010;19(2):141-146. [doi: 10.1111/j.1521-0391.2009.00017.x].
 
51. A Multi-Site, Two-Phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, Design, and Methodology. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Provost, Scott E. ; Huang, Zhen ; Jacobs, Petra ; Hasson, Albert L. ; Lindblad, Robert ; Connery, Hilary Smith ; Prather, Kristi ; Ling, Walter
 Contemporary Clinical Trials 2010;31(2):189-199. [doi: 10.1016/j.cct.2010.01.003].
 
52. Use of an Adaptive Treatment Research Design in a CTN Study of Prescription Opioid Dependence Treatment. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Byrne, Mimmie ; Sullivan, Carl Rollynn ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Reno/Sparks, Nevada, June 20-25, 2009.
 
53. Predictors of Outcome for Short-Term Medically Supervised Opioid Withdrawal During a Randomized, Multicenter Trial of Buprenorphine-Naloxone and Clonidine in the NIDA Clinical Trials Network. doc type
  Ziedonis, Douglas M. ; Amass, Leslie ; Steinberg, Marc ; Woody, George E. ; Krejci, Jonathan ; Annon, Jeffrey J. ; Cohen, Allan J. ; Waite-O'Brien, Nancy ; Stein, Susan M. ; McCarty, Dennis ; Reid, Malcolm S. ; Brown, Lawrence S. Jr. ; Maslansky, Robert ; Winhusen, Theresa M. ; Babcock, Dean ; Brigham, Gregory S. ; Muir, Joan A. ; Orr, Deborah ; Buchan, Betty J. ; Horton, Terry ; Ling, Walter
 Drug and Alcohol Dependence 2009;99(1-3):28-36. [doi: 10.1016/j.drugalcdep.2008.06.016].
 
54. Buprenorphine Tapering Schedule and Illicit Opioid Use. doc type doc type
  Ling, Walter ; Hillhouse, Maureen P. ; Domier, Catherine P. ; Doraimani, Geetha ; Hunter, Jeremy ; Thomas, Christie ; Jenkins, Jessica ; Hasson, Albert L. ; Annon, Jeffrey J. ; Saxon, Andrew J. ; Selzer, Jeffrey A. ; Boverman, Joshua ; Bilangi, Richard
 Addiction 2009;104(2):256-265 [doi: 10.1111/j.1360-0443.2008.02455.x].
 
55. A Multi-Center Randomized Trial of Buprenorphine-Naloxone Versus Clonidine for Opioid Detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network. doc type doc type
  Ling, Walter ; Amass, Leslie ; Shoptaw, Steven ; Annon, Jeffrey J. ; Hillhouse, Maureen P. ; Babcock, Dean ; Brigham, Gregory S. ; Harrer, Judith M. ; Reid, Malcolm S. ; Muir, Joan A. ; Buchan, Betty J. ; Orr, Deborah ; Woody, George E. ; Krejci, Jonathan ; Ziedonis, Douglas M. ; CTN Buprenorphine Study Team (CTN-0001/0002)
 Addiction 2005; 100(8):1090-1100. [doi: 10.1111/j.1360-0443.2005.01154.x] Correction: Addiction 2006;101(9):1374.
 
56. Bringing Buprenorphine-Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field Experience. doc type
  Amass, Leslie ; Ling, Walter ; Freese, Thomas E. ; Reiber, Chris ; Annon, Jeffrey J. ; Cohen, Allan J. ; McCarty, Dennis ; Reid, Malcolm S. ; Brown, Lawrence S. Jr. ; Clark, Cynthia ; Ziedonis, Douglas M. ; Krejci, Jonathan ; Stine, Susan M. ; Winhusen, Theresa M. ; Brigham, Gregory S. ; Babcock, Dean ; Muir, Joan A. ; Buchan, Betty J. ; Horton, Terry
 American Journal on Addictions 2004; 13 (Suppl 1): S42-S66. [doi: 10.1080/10550490490440807].
 

New Search